151 related articles for article (PubMed ID: 23669732)
1. Evaluation of the retinoids with cisplatin and vincristine in xenograft models of neuroblastoma.
Norris RE; Nguyen VT; Adamson PC
J Pediatr Hematol Oncol; 2014 Jan; 36(1):e23-7. PubMed ID: 23669732
[TBL] [Abstract][Full Text] [Related]
2. Synergistic induction of apoptosis of neuroblastoma by fenretinide or CD437 in combination with chemotherapeutic drugs.
Lovat PE; Ranalli M; Bernassola F; Tilby M; Malcolm AJ; Pearson AD; Piacentini M; Melino G; Redfern CP
Int J Cancer; 2000 Dec; 88(6):977-85. PubMed ID: 11093824
[TBL] [Abstract][Full Text] [Related]
3. P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.
Lopez-Barcons L; Maurer BJ; Kang MH; Reynolds CP
Int J Cancer; 2017 Jul; 141(2):405-413. PubMed ID: 28340497
[TBL] [Abstract][Full Text] [Related]
4. Gene Expression Signature of Acquired Chemoresistance in Neuroblastoma Cells.
Jemaà M; Sime W; Abassi Y; Lasorsa VA; Bonne Køhler J; Michaelis M; Cinatl J; Capasso M; Massoumi R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948088
[TBL] [Abstract][Full Text] [Related]
5. Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation.
Hahn CK; Ross KN; Warrington IM; Mazitschek R; Kanegai CM; Wright RD; Kung AL; Golub TR; Stegmaier K
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9751-6. PubMed ID: 18607002
[TBL] [Abstract][Full Text] [Related]
6. Retinoid therapy of childhood cancer.
Reynolds CP; Lemons RS
Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
[TBL] [Abstract][Full Text] [Related]
7. A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model.
Orienti I; Nguyen F; Guan P; Kolla V; Calonghi N; Farruggia G; Chorny M; Brodeur GM
Drug Des Devel Ther; 2019; 13():4305-4319. PubMed ID: 31908416
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
Bandyopadhyay A; Favours E; Phelps DA; Pozo VD; Ghilu S; Kurmashev D; Michalek J; Trevino A; Guttridge D; London C; Hirotani K; Zhang L; Kurmasheva RT; Houghton PJ
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29080385
[TBL] [Abstract][Full Text] [Related]
9. Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing program.
Morton CL; Maris JM; Keir ST; Gorlick R; Kolb EA; Billups CA; Wu J; Smith MA; Houghton PJ
Pediatr Blood Cancer; 2012 Apr; 58(4):566-71. PubMed ID: 21538824
[TBL] [Abstract][Full Text] [Related]
10. Effects of PI3K and FGFR inhibitors alone and in combination, and with/without cytostatics in childhood neuroblastoma cell lines.
Holzhauser S; Lukoseviciute M; Papachristofi C; Vasilopoulou C; Herold N; Wickström M; Kostopoulou ON; Dalianis T
Int J Oncol; 2021 Feb; 58(2):211-225. PubMed ID: 33491755
[TBL] [Abstract][Full Text] [Related]
11. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
12. Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Norris RE; Minturn JE; Brodeur GM; Maris JM; Adamson PC
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1469-75. PubMed ID: 21484309
[TBL] [Abstract][Full Text] [Related]
13. Reactive Oxygen Species Mediates the Synergistic Activity of Fenretinide Combined with the Microtubule Inhibitor ABT-751 against Multidrug-Resistant Recurrent Neuroblastoma Xenografts.
Chen NE; Maldonado NV; Khankaldyyan V; Shimada H; Song MM; Maurer BJ; Reynolds CP
Mol Cancer Ther; 2016 Nov; 15(11):2653-2664. PubMed ID: 27530131
[TBL] [Abstract][Full Text] [Related]
14. Discovery of
Sime W; Jemaà M; Abassi Y; Lasorsa VA; Bonne Køhler J; Hansson K; Bexell D; Michaelis M; Cinatl J; Strand D; Capasso M; Massoumi R
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911859
[TBL] [Abstract][Full Text] [Related]
15. Distinct properties of fenretinide and CD437 lead to synergistic responses with chemotherapeutic reagents.
Lovat PE; Ranalli M; Bernassola F; Tilby M; Malcolm AJ; Pearson AD; Piacentini M; Melino G; Redfern CP
Med Pediatr Oncol; 2000 Dec; 35(6):663-8. PubMed ID: 11107142
[TBL] [Abstract][Full Text] [Related]
16. Enhancing sustained-release local therapy: Single versus dual chemotherapy for the treatment of neuroblastoma.
Taylor JS; Yavuz B; Zeki J; Wood L; Ikegaki N; Coburn J; Harrington K; Shimada H; Kaplan DL; Chiu B
Surgery; 2020 Jun; 167(6):969-977. PubMed ID: 32122657
[TBL] [Abstract][Full Text] [Related]
17. Premature physeal closure following 13-cis-retinoic acid and prolonged fenretinide administration in neuroblastoma.
Steineck A; MacKenzie JD; Twist CJ
Pediatr Blood Cancer; 2016 Nov; 63(11):2050-3. PubMed ID: 27399265
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a Three Drug-Based Therapy for Neuroblastoma in Mice.
Garbati P; Barbieri R; Calderoni M; Baldini F; Nizzari M; Modesto P; Florio T; Pagano A
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201814
[TBL] [Abstract][Full Text] [Related]
19. Prediction of neuroblastoma cell response to treatment with natural or synthetic retinoids using selected protein biomarkers.
Dobrotkova V; Chlapek P; Jezova M; Adamkova K; Mazanek P; Sterba J; Veselska R
PLoS One; 2019; 14(6):e0218269. PubMed ID: 31188873
[TBL] [Abstract][Full Text] [Related]
20. Effect of cytotoxic agents and retinoic acid on Myc-N protein expression in neuroblastoma.
Aktas S; Altun Z; Erbayraktar Z; Aygun N; Olgun N
Appl Immunohistochem Mol Morphol; 2010 Jan; 18(1):86-9. PubMed ID: 19550295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
